$3.42
-0.13-3.53%
Ult. Agg.: Nov 17, 1:24 PM

The average analyst price target for Starling Oncology is $9.25, 170.9% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $8 to $10. The latest change came on Nov 6, 2026, when Lake Street lowered its price target on Starling Oncology from $10 to $8 and kept a Buy rating.
Price Target Range — 1 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months